These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 25590316

  • 1. Factors driving the aspirin exacerbated respiratory disease phenotype.
    Steinke JW, Borish L.
    Am J Rhinol Allergy; 2015; 29(1):35-40. PubMed ID: 25590316
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization.
    Steinke JW, Payne SC, Borish L.
    J Allergy (Cairo); 2012; 2012():182090. PubMed ID: 22262978
    [Abstract] [Full Text] [Related]

  • 3. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
    Steinke JW, Payne SC, Borish L.
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):719-734. PubMed ID: 27712766
    [Abstract] [Full Text] [Related]

  • 4. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
    Steinke JW, Liu L, Huyett P, Negri J, Payne SC, Borish L.
    J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
    [Abstract] [Full Text] [Related]

  • 5. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway.
    Liu T, Kanaoka Y, Barrett NA, Feng C, Garofalo D, Lai J, Buchheit K, Bhattacharya N, Laidlaw TM, Katz HR, Boyce JA.
    J Immunol; 2015 Oct 15; 195(8):3537-45. PubMed ID: 26342029
    [Abstract] [Full Text] [Related]

  • 6. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.
    Liu T, Barrett NA, Kanaoka Y, Yoshimoto E, Garofalo D, Cirka H, Feng C, Boyce JA.
    J Immunol; 2018 Feb 01; 200(3):915-927. PubMed ID: 29282304
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease.
    Steinke JW, Negri J, Liu L, Payne SC, Borish L.
    J Immunol; 2014 Jul 01; 193(1):41-7. PubMed ID: 24890720
    [Abstract] [Full Text] [Related]

  • 10. Effect of TGF-β1 on eosinophils to induce cysteinyl leukotriene E4 production in aspirin-exacerbated respiratory disease.
    Choi Y, Sim S, Lee DH, Lee HR, Ban GY, Shin YS, Kim YK, Park HS.
    PLoS One; 2021 Jul 01; 16(8):e0256237. PubMed ID: 34437574
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes.
    Liu T, Laidlaw TM, Katz HR, Boyce JA.
    Proc Natl Acad Sci U S A; 2013 Oct 15; 110(42):16987-92. PubMed ID: 24085850
    [Abstract] [Full Text] [Related]

  • 12. Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated with aspirin desensitization.
    Steinke JW, Culp JA, Kropf E, Borish L.
    J Allergy Clin Immunol; 2009 Oct 15; 124(4):724-30.e4. PubMed ID: 19767084
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 resistance in granulocytes from patients with aspirin-exacerbated respiratory disease.
    Laidlaw TM, Cutler AJ, Kidder MS, Liu T, Cardet JC, Chhay H, Feng C, Boyce JA.
    J Allergy Clin Immunol; 2014 Jun 15; 133(6):1692-701.e3. PubMed ID: 24486071
    [Abstract] [Full Text] [Related]

  • 19. Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.
    Cahill KN, Bensko JC, Boyce JA, Laidlaw TM.
    J Allergy Clin Immunol; 2015 Jan 15; 135(1):245-52. PubMed ID: 25218285
    [Abstract] [Full Text] [Related]

  • 20. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
    Laidlaw TM, Buchheit KM, Cahill KN, Hacker J, Cho L, Cui J, Feng C, Chen CC, Le M, Israel E, Boyce JA.
    J Allergy Clin Immunol; 2023 Sep 15; 152(3):700-710.e3. PubMed ID: 37068712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.